Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan.
Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu 300193, Taiwan.
ACS Chem Biol. 2024 Sep 20;19(9):1982-1990. doi: 10.1021/acschembio.4c00251. Epub 2024 Aug 20.
Microcin J25 (MccJ25), a lasso peptide antibiotic with a unique structure that resembles the lariat knot, has been a topic of intense interest since its discovery in 1992. The precursor (McjA) contains a leader and a core segment. McjB is a protease activated upon binding to the leader, and McjC converts the core segment into the mature MccJ25. Previous studies suggested that these biosynthetic steps likely proceed in a (nearly) concerted fashion; however, there is only limited information regarding the structural and molecular intricacies of MccJ25 biosynthesis. To close this knowledge gap, we used AlphaFold2 to predict the structure of the precursor (McjA) in complex with its biosynthetic enzymes (McjB and McjC) and queried the critical predicted features by protein engineering. Based on the predicted structure, we designed protein variants to show that McjB can still be functional and form a proficient biosynthetic complex with McjC when its recognition and protease domains were circularly permutated or split into separate proteins. Specific residues important for McjA recognition were also identified, which permitted us to pinpoint a compensatory mutation (McjB) to restore McjA/McjB interaction that rescued an otherwise nearly nonproductive precursor variant (McjA). Studies of McjA, McjB, and McjC have long been mired by them being extremely difficult to handle experimentally, and our results suggest that the AF2 predicted ternary complex structure may serve as a reasonable starting point for understanding MccJ25 biosynthesis. The prediction-validation workflow presented herein combined artificial intelligence and laboratory experiments constructively to gain new insights.
微菌素 J25(MccJ25)是一种具有独特结构的套索肽抗生素,类似于套索结,自 1992 年发现以来一直是研究的热点。前体(McjA)包含一个先导序列和一个核心片段。McjB 是一种在与先导序列结合时被激活的蛋白酶,而 McjC 将核心片段转化为成熟的 MccJ25。先前的研究表明,这些生物合成步骤可能以(几乎)协同的方式进行;然而,关于 MccJ25 生物合成的结构和分子复杂性的信息非常有限。为了弥补这一知识空白,我们使用 AlphaFold2 预测了前体(McjA)与生物合成酶(McjB 和 McjC)复合物的结构,并通过蛋白质工程对关键预测特征进行了查询。基于预测结构,我们设计了蛋白质变体,以证明 McjB 仍然具有功能,并且当它的识别和蛋白酶结构域被环状排列或分裂成单独的蛋白质时,仍可以与 McjC 形成有效的生物合成复合物。还确定了对 McjA 识别很重要的特定残基,这使我们能够确定一个补偿性突变(McjB),以恢复 McjA/McjB 相互作用,从而挽救了一个原本几乎没有产物的前体变体(McjA)。对 McjA、McjB 和 McjC 的研究一直受到它们在实验上极难处理的困扰,我们的结果表明,AF2 预测的三元复合物结构可能是理解 MccJ25 生物合成的一个合理起点。本文提出的预测-验证工作流程建设性地结合了人工智能和实验室实验,以获得新的见解。